---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-336057"
form_type: "8-K"
ticker: "LFST"
cik: "0001845257"
company_name: "LifeStance Health Group, Inc."
filed_at: "2026-08-06T00:21:23+00:00"
generated_at: "2026-08-06T10:10:19.056517+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# LifeStance Q2 revenue up 26% to $435.4M, net income $23.6M, raises FY2026 guidance, announces $100M buyback

## Summary
- Revenue $435.4M (+26% YoY), net income $23.6M vs loss $3.8M.
- Adjusted EBITDA $66.0M (+94% YoY), margin 15.2% vs 9.8%.
- Clinician base 8,542 (+11% YoY), visit volumes 2.6M (+19%).
- FY2026 revenue guidance raised to $1.685-1.725B, Adjusted EBITDA $215-235M.
- Board approved new $100M share repurchase program, replacing prior $100M program.

## SEC filing metadata
- accession: 0001193125-26-336057
- form_type: 8-K
- ticker: LFST
- cik: 0001845257
- company_name: LifeStance Health Group, Inc.
- filed_at: 2026-08-06T00:21:23+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1845257/000119312526336057/0001193125-26-336057-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1845257/000119312526336057/lfst-20260806.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-336057
- JSON: https://secwatch.observer/filing/0001193125-26-336057.json
- Plain text: https://secwatch.observer/filing/0001193125-26-336057.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.